Freestone Capital Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Freestone Capital Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$357K	Buy
2022 Q3	–	Sell
2022 Q2	$286K	Sell
2022 Q1	$369K	Sell
2021 Q4	$320K	Buy
2021 Q3	–	Sell
2021 Q2	$251K	Sell
2021 Q1	$275K	Buy
2020 Q4	$226K	Buy
2020 Q3	$196K	Buy